Loading clinical trials...
Loading clinical trials...
Clinical Efficacy and Health Economic Evaluation of Fecal Molecular Susceptibility-guided Therapy for Helicobacter Pylori Infection Rescue Treatment: Multicenter Randomized Controlled Study
Conditions
Interventions
7-day fecal molecular susceptibility-guided therapy
14-day fecal molecular susceptibility-guided therapy
Locations
4
China
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China
Shanghai Jiangong Hospitail.
Shanghai, Shanghai Municipality, China
Shanghai Tenth People Hospital
Shanghai, Shanghai Municipality, China
Zhongshan Hospital, Fudan University
Shanghai, China
Start Date
February 28, 2026
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2028
Last Updated
February 12, 2026
NCT07537634
NCT07516262
NCT07335406
NCT07179159
NCT07293910
NCT07358130
Lead Sponsor
Shanghai Zhongshan Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions